Navigation Links
ISBT 128 Labeling Implementation Date Looms for Blood Centers
Date:3/26/2008

Mediware announces readiness for new standards

LENEXA, Kan., Mar. 26 /PRNewswire-FirstCall/ -- Mediware Information Systems (Nasdaq: MEDW), a provider of ClosedLoop(TM) clinical systems for blood and medication management, has announced its blood management software systems, including HCLL(TM) Transfusion software for hospital blood banks and LifeTrak(R) software for blood centers, are ready to accommodate the new global blood labeling standards being required in the United States.

With a widening demand for blood products and a global need for safety in blood transfusions, the American Association of Blood Banks (AABB) has adopted a global standard for the labeling of blood products collected and used throughout the United States. The standard, called ISBT (International Society of Blood Transfusion) 128, was developed to improve the identification and processing of human blood, tissue and organ products across international borders and disparate health care systems. The AABB, in Association Bulletin #05-12, established May 1, 2008 as the implementation deadline for its accredited blood centers and hospital transfusion services.

Implementing systems to support this new standard has been a long and difficult process for blood centers and hospitals. Mediware, which has been a market leader in blood management systems for more than 25 years, released a version of the LifeTrak software that addresses the ISBT standards in May of 2007. As the deadline looms, Mediware believes its more than 65 blood center customer facilities are well positioned for the May 1 cut off. Mediware's HCLL Transfusion product has addressed the ISBT standards since its inception and Mediware's BiologiCare(TM) biologics management platform will also fully support ISBT upon its commercial release in June 2008.

"ISBT certainly has the attention of Mediware, our customers, and the industry as a whole," said John Damgaard, senior vice president and chief operating officer at Mediware. "We have worked feverishly to support our customers as they transition to this important global labeling standard for blood and biologics management."

Blood Centers and hospitals that have not implemented systems that address the ISBT requirements by the May 1 deadline must file with the AABB and have a variance approved which documents when the facility will have the necessary systems in place.

Damgaard continued, "We are very confident that our software has our customers well positioned to transition to the new standard. Further, our product specialists are ready to help facilities who have not licensed our software, have been unable to meet the deadline and have been required to file for a variance."

Mediware has long been a leader in the clinical systems supporting donor centers and the Company's LifeTrak(R) product supports more than 65 customer facilities, including many of the largest blood collection organizations in the country. This product line was recently expanded to include internet based products for donor recruiting, donor retention and electronic hospital ordering, which were added last year as a part of the Integrated Marketing Solutions (IMS) acquisition. The company's strategy for this product group is to deliver a complete, ClosedLoop environment to help customers streamline operational processes from initial recruitment to the sale and ultimate use of the blood product.

About Mediware

Mediware delivers blood and medication management software systems that encapsulate information supporting patient therapies, reinforce patient safety practices and improve efficiencies to lower costs. Mediware's customers include prestigious hospitals, clinics, correctional institutions, blood centers and other public and private health care institutions throughout the world. For more information about Mediware products and services, visit our web site at http://www.mediware.com .

Certain statements in this press release may constitute "forward-looking" statements within the meaning of the Private Securities Litigation Reform Act of 1995, as the same may be amended from time to time (the "Act") and in releases made by the SEC from time to time. Such forward-looking statements are not based on historical facts and involve known and unknown risks, uncertainties and other factors disclosed in the Company's Annual Report on Form 10-K for the year ended June 30, 2007, which may cause the actual results of the Company to be materially different from any future results expressed or implied by such forward-looking statements. The Company disclaims any obligation to update its forward-looking statements.


'/>"/>
SOURCE Mediware Information Systems
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. FDA Approves Expanded Labeling for Campath(R) to Include First-line Treatment for Leading Form of Adult Leukemia
2. IOM workshop on less confusing drug labeling, Oct. 12
3. GSK Revises US Labeling for Avandia(R)
4. FDA Sunscreen Labeling Decision Delayed Another Month, Leading U.S. Physician to Say, Enough Is Enough
5. Truthful Labeling Coalition Welcomes Perdue Farms
6. Consumer Group Criticizes NYC Board of Health Over Menu Labeling Bill
7. FDA Approves Labeling Change for Non-Drowsy CLARITIN(R)
8. American Society for Dermatologic Surgery Supports Current Labeling of Allergans Botox(R) Products
9. Keane Wins $1 Million Electronic Medical Record (EMR) Implementation at New Jersey-Based Acute Care Facility
10. AHIMA Signs Contract With CMS for ICD-10 Implementation Assessment and Training
11. Remarks by President Bush, Senator Bob Dole and Secretary Donna Shalala on Commission on Care for Americas Returning Wounded Warriors Report Implementation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery services, can ... Surgery and to Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey ... cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe ... from the David Geffen School of Medicine at UCLA. He trained in Internal Medicine ... his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the ...
(Date:6/24/2016)... , ... June 24, 2016 , ... A recent ... most people are unfamiliar with. The article goes on to state that individuals are ... many of these less common operations such as calf and cheek reduction. The Los ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... Scientific Sessions in Dallas that it will receive two significant new grants to ... came as PHA marked its 25th anniversary by recognizing patients, medical professionals and ...
(Date:6/24/2016)... ... 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join ... wage raise to $12 an hour by 2020 and then adjusting it yearly to increase ... of the minimum wage, assure the wage floor does not erode again, and make future ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016  Collagen Matrix, ... design, development and manufacturing of collagen and mineral ... announced today that Bill Messer has ... Marketing to further leverage the growing portfolio of ... devices. Bill joins the Collagen Matrix ...
(Date:6/24/2016)... 2016 The Academy of Managed Care Pharmacy ... that would allow biopharmaceutical companies to more easily share ... formulary and coverage decisions, a move that addresses the ... The recommendations address restrictions in the sharing ... drug label, a prohibition that hinders decision makers from ...
(Date:6/24/2016)... , June 24, 2016   Pulmatrix, Inc ., ... developing innovative inhaled drugs, announced today that it was ... Investments reconstituted its comprehensive set of U.S. and ... "This is an important milestone for Pulmatrix," said Chief ... shareholder awareness of our progress in developing drugs for ...
Breaking Medicine Technology: